Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

In a sub-chronic oral toxicity study with NX 8000J no adverse effects were noted. Therefore the NOAEL is set at 1682 mg/kg bw/day

Key value for chemical safety assessment

Repeated dose toxicity: via oral route - systemic effects

Endpoint conclusion
Dose descriptor:
NOAEL
1 682 mg/kg bw/day

Additional information

The oral administration of NX 8000J to rats by dietary admixture for a period of ninety consecutive days at a maximum dose level of 1682 mg/kg bw/day resulted in treatment-related histopathological changes at 20000 ppm. The changes however, were considered not to represent an adverse health effect and as such, the ‘No Observed Adverse Effect Level’ (NOAEL) was considered as 1682 mg/kg bw/day.

Dietary administration of the substance to rats for a period of fourteen consecutive days at dietary concentrations of up to 2544 mg/kg bw/day, produced no toxicologically significant changes in the parameters measured. The “No Observed Effect Level” (NOEL) was, therefore, considered to be 2544 mg/kg bw/day.

Justification for classification or non-classification

Based on the results of the oral repeated dose toxicity studies, NX 8000J does not need to be classified for repeated dose toxicity according to EU Directive 67/548/EEC and EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008.